Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
CXT vs VRNT vs NICE vs CIX vs FIVN
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Application
Security & Protection Services
Software - Infrastructure
CXT vs VRNT vs NICE vs CIX vs FIVN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Software - Infrastructure | Software - Application | Security & Protection Services | Software - Infrastructure |
| Market Cap | $2.61B | $1.24B | $5.62B | $293M | $1.69B |
| Revenue (TTM) | $1.71B | $894M | $3.01B | $159M | $1.17B |
| Net Income (TTM) | $130M | $61M | $529M | $20M | $57M |
| Gross Margin | 42.0% | 69.9% | 65.8% | 31.1% | 55.1% |
| Operating Margin | 13.9% | 8.6% | 20.7% | 15.0% | 4.7% |
| Forward P/E | 10.6x | 7.0x | 8.4x | 88.0x | 6.8x |
| Total Debt | $1.14B | $448M | $164M | $0.00 | $847M |
| Cash & Equiv. | $234M | $216M | $379M | $54M | $232M |
CXT vs VRNT vs NICE vs CIX vs FIVN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Crane NXT, Co. (CXT) | 100 | 234.2 | +134.2% |
| Verint Systems Inc. (VRNT) | 100 | 43.7 | -56.3% |
| NICE Ltd. (NICE) | 100 | 49.8 | -50.2% |
| CompX International… (CIX) | 100 | 168.8 | +68.8% |
| Five9, Inc. (FIVN) | 100 | 21.2 | -78.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CXT vs VRNT vs NICE vs CIX vs FIVN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CXT ranks third and is worth considering specifically for growth.
- 11.4% revenue growth vs VRNT's -0.1%
VRNT is the clearest fit if your priority is momentum.
- +13.8% vs NICE's -43.4%
NICE carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.48, Low D/E 4.2%, current ratio 1.55x
- PEG 0.32 vs CIX's 6.40
- Lower P/E (8.4x vs 88.0x), PEG 0.32 vs 6.40
- 17.6% margin vs FIVN's 4.9%
CIX is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 0 yrs, beta 0.56, yield 9.3%
- 223.2% 10Y total return vs CXT's 172.4%
- Beta 0.56, yield 9.3%, current ratio 5.87x
- 9.3% yield, vs CXT's 1.5%, (2 stocks pay no dividend)
FIVN is the clearest fit if your priority is growth exposure.
- Rev growth 10.3%, EPS growth 370.6%, 3Y rev CAGR 13.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.4% revenue growth vs VRNT's -0.1% | |
| Value | Lower P/E (8.4x vs 88.0x), PEG 0.32 vs 6.40 | |
| Quality / Margins | 17.6% margin vs FIVN's 4.9% | |
| Stability / Safety | Beta 0.48 vs FIVN's 1.70, lower leverage | |
| Dividends | 9.3% yield, vs CXT's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +13.8% vs NICE's -43.4% | |
| Efficiency (ROA) | 12.8% ROA vs VRNT's 2.8%, ROIC 20.0% vs 5.3% |
CXT vs VRNT vs NICE vs CIX vs FIVN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CXT vs VRNT vs NICE vs CIX vs FIVN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 2 of 6 categories
CIX leads 2 • CXT leads 0 • VRNT leads 0 • FIVN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $3.0B annually — 19.0x CIX's $159M. NICE is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to FIVN's 4.9%. On growth, CXT holds the edge at +17.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.7B | $894M | $3.0B | $159M | $1.2B |
| EBITDAEarnings before interest/tax | $314M | $127M | $841M | $26M | $140M |
| Net IncomeAfter-tax profit | $130M | $61M | $529M | $20M | $57M |
| Free Cash FlowCash after capex | $206M | $118M | $569M | $22M | $206M |
| Gross MarginGross profit ÷ Revenue | +42.0% | +69.9% | +65.8% | +31.1% | +55.1% |
| Operating MarginEBIT ÷ Revenue | +13.9% | +8.6% | +20.7% | +15.0% | +4.7% |
| Net MarginNet income ÷ Revenue | +7.6% | +6.9% | +17.6% | +12.7% | +4.9% |
| FCF MarginFCF ÷ Revenue | +12.0% | +13.2% | +18.9% | +13.9% | +17.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +17.4% | -1.0% | +9.5% | +0.7% | +9.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -71.1% | -5.1% | -61.7% | +14.3% | +20.0% |
Valuation Metrics
NICE leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.6x trailing earnings, NICE trades at a 80% valuation discount to FIVN's 48.0x P/E. Adjusting for growth (PEG ratio), NICE offers better value at 0.36x vs CIX's 1.09x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $1.2B | $5.6B | $293M | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $1.5B | $5.4B | $239M | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 18.12x | 19.72x | 9.59x | 15.03x | 48.04x |
| Forward P/EPrice ÷ next-FY EPS est. | 10.61x | 7.00x | 8.38x | 87.96x | 6.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x | 0.36x | 1.09x | — |
| EV / EBITDAEnterprise value multiple | 9.49x | 9.46x | 6.40x | 9.09x | 16.78x |
| Price / SalesMarket cap ÷ Revenue | 1.57x | 1.37x | 1.91x | 1.85x | 1.47x |
| Price / BookPrice ÷ Book value/share | 2.09x | 0.97x | 1.51x | 2.11x | 2.45x |
| Price / FCFMarket cap ÷ FCF | 13.15x | 8.75x | 7.99x | 15.30x | 8.41x |
Profitability & Efficiency
CIX leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CIX delivers a 14.3% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $5 for VRNT. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to FIVN's 1.08x. On the Piotroski fundamental quality scale (0–9), FIVN scores 8/9 vs CXT's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.6% | +4.6% | +14.0% | +14.3% | +7.4% |
| ROA (TTM)Return on assets | +4.1% | +2.8% | +10.3% | +12.8% | +3.2% |
| ROICReturn on invested capital | +10.2% | +5.3% | +13.2% | +20.0% | +1.7% |
| ROCEReturn on capital employed | +12.1% | +5.9% | +16.1% | +15.8% | +2.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 7 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.91x | 0.34x | 0.04x | — | 1.08x |
| Net DebtTotal debt minus cash | $906M | $233M | -$216M | -$54M | $615M |
| Cash & Equiv.Liquid assets | $234M | $216M | $379M | $54M | $232M |
| Total DebtShort + long-term debt | $1.1B | $448M | $164M | $0 | $847M |
| Interest CoverageEBIT ÷ Interest expense | 6.51x | 8.24x | — | — | 7.94x |
Total Returns (Dividends Reinvested)
CIX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CIX five years ago would be worth $14,982 today (with dividends reinvested), compared to $1,327 for FIVN. Over the past 12 months, VRNT leads with a +13.8% total return vs NICE's -43.4%. The 3-year compound annual growth rate (CAGR) favors CIX at 16.1% vs FIVN's -27.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.7% | — | -17.2% | +4.6% | +17.5% |
| 1-Year ReturnPast 12 months | -9.7% | +13.8% | -43.4% | -3.1% | -16.2% |
| 3-Year ReturnCumulative with dividends | -3.6% | -39.3% | -50.8% | +56.6% | -61.5% |
| 5-Year ReturnCumulative with dividends | +41.6% | -55.8% | -59.3% | +49.8% | -86.7% |
| 10-Year ReturnCumulative with dividends | +172.4% | -37.1% | +46.1% | +223.2% | +124.4% |
| CAGR (3Y)Annualised 3-year return | -1.2% | -15.3% | -21.1% | +16.1% | -27.3% |
Risk & Volatility
Evenly matched — VRNT and NICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than FIVN's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VRNT currently trades 89.8% from its 52-week high vs NICE's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.40x | 1.25x | 0.48x | 0.56x | 1.70x |
| 52-Week HighHighest price in past year | $69.00 | $22.84 | $180.61 | $32.30 | $30.38 |
| 52-Week LowLowest price in past year | $39.23 | $16.23 | $90.70 | $20.29 | $13.29 |
| % of 52W HighCurrent price vs 52-week peak | +65.7% | +89.8% | +51.3% | +73.5% | +72.7% |
| RSI (14)Momentum oscillator 0–100 | 47.0 | 68.4 | 40.1 | 53.3 | 68.9 |
| Avg Volume (50D)Average daily shares traded | 690K | 0 | 635K | 3K | 2.8M |
Analyst Outlook
Evenly matched — CXT and CIX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CXT as "Buy", VRNT as "Hold", NICE as "Buy", FIVN as "Buy". Consensus price targets imply 60.0% upside for NICE (target: $148) vs 24.4% for FIVN (target: $28). For income investors, CIX offers the higher dividend yield at 9.26% vs CXT's 1.48%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | — | Buy |
| Price TargetConsensus 12-month target | $63.00 | $32.57 | $148.38 | — | $27.50 |
| # AnalystsCovering analysts | 7 | 16 | 23 | — | 41 |
| Dividend YieldAnnual dividend ÷ price | +1.5% | +1.6% | — | +9.3% | — |
| Dividend StreakConsecutive years of raises | 2 | 0 | 0 | 0 | — |
| Dividend / ShareAnnual DPS | $0.67 | $0.32 | — | $2.20 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.8% | +8.8% | 0.0% | +3.0% |
NICE leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). CIX leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
CXT vs VRNT vs NICE vs CIX vs FIVN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CXT or VRNT or NICE or CIX or FIVN a better buy right now?
For growth investors, Crane NXT, Co.
(CXT) is the stronger pick with 11. 4% revenue growth year-over-year, versus -0. 1% for Verint Systems Inc. (VRNT). NICE Ltd. (NICE) offers the better valuation at 9. 6x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Crane NXT, Co. (CXT) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CXT or VRNT or NICE or CIX or FIVN?
On trailing P/E, NICE Ltd.
(NICE) is the cheapest at 9. 6x versus Five9, Inc. at 48. 0x. On forward P/E, Five9, Inc. is actually cheaper at 6. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NICE Ltd. wins at 0. 32x versus CompX International Inc. 's 6. 40x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CXT or VRNT or NICE or CIX or FIVN?
Over the past 5 years, CompX International Inc.
(CIX) delivered a total return of +49. 8%, compared to -86. 7% for Five9, Inc. (FIVN). Over 10 years, the gap is even starker: CIX returned +223. 2% versus VRNT's -37. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CXT or VRNT or NICE or CIX or FIVN?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 48β versus Five9, Inc. 's 1. 70β — meaning FIVN is approximately 253% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 108% for Five9, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CXT or VRNT or NICE or CIX or FIVN?
By revenue growth (latest reported year), Crane NXT, Co.
(CXT) is pulling ahead at 11. 4% versus -0. 1% for Verint Systems Inc. (VRNT). On earnings-per-share growth, the picture is similar: Five9, Inc. grew EPS 370. 6% year-over-year, compared to -21. 6% for Crane NXT, Co.. Over a 3-year CAGR, FIVN leads at 13. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CXT or VRNT or NICE or CIX or FIVN?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus 3. 4% for Five9, Inc. — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus 2. 8% for FIVN. At the gross margin level — before operating expenses — VRNT leads at 71. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CXT or VRNT or NICE or CIX or FIVN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NICE Ltd. (NICE) is the more undervalued stock at a PEG of 0. 32x versus CompX International Inc. 's 6. 40x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Five9, Inc. (FIVN) trades at 6. 8x forward P/E versus 88. 0x for CompX International Inc. — 81. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NICE: 60. 0% to $148. 38.
08Which pays a better dividend — CXT or VRNT or NICE or CIX or FIVN?
In this comparison, CIX (9.
3% yield), VRNT (1. 6% yield), CXT (1. 5% yield) pay a dividend. NICE, FIVN do not pay a meaningful dividend and should not be held primarily for income.
09Is CXT or VRNT or NICE or CIX or FIVN better for a retirement portfolio?
For long-horizon retirement investors, CompX International Inc.
(CIX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 56), 9. 3% yield, +223. 2% 10Y return). Five9, Inc. (FIVN) carries a higher beta of 1. 70 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CIX: +223. 2%, FIVN: +124. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CXT and VRNT and NICE and CIX and FIVN?
These companies operate in different sectors (CXT (Industrials) and VRNT (Technology) and NICE (Technology) and CIX (Industrials) and FIVN (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CXT is a small-cap quality compounder stock; VRNT is a small-cap quality compounder stock; NICE is a small-cap deep-value stock; CIX is a small-cap deep-value stock; FIVN is a small-cap quality compounder stock. CXT, VRNT, CIX pay a dividend while NICE, FIVN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.